InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the full record of transactions filed by Miller Ann Calby, 董事. Officer active across 3 companies, notably INOVIO PHARMACEUTICALS, INC.. Cumulatively, 8 disclosures have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €121k. Activity tracked since 10 June 2021. The latest transaction was filed on 15 June 2021 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Miller Ann Calby
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报8 总计
2,167 股Common StockSEC:0001055726-25-000039:0
2,166 股Common StockSEC:0001055726-24-000034:0
19,000 股Common StockSEC:0001055726-23-000034:0
18,000 股Common StockSEC:0001055726-22-000037:0
4,273 股Common StockSEC:0001055726-22-000026:0
27,858 股0COMMON STOCKSEC:0001209191-21-041787:0
12,874 股@ US$11.4305100.0% 占其流量COMMON STOCKSEC:0001209191-21-039897:0
8,700 股Common StockSEC:0001055726-21-000048:0
8 条申报中的 8 条
About Miller Ann Calby
Ann Calby Miller is a Board Member at INOVIO Pharmaceuticals, Inc. and PUMA Biotechnology, Inc. She brings significant expertise in corporate governance and business strategy. Her role involves overseeing operations and guiding strategic decisions to ensure the growth and sustainability of the companies. Miller is valued for her ability to combine innovation with accountability in the biopharmaceutical sector.
